Population A healthy (n = 67) | Population A with CV risks (n = 20) | Population A cardiac (n = 41) | Population B cardiac (n = 163) | |
---|---|---|---|---|
Age, y | 37 ± 20* | 59 ± 11 | 67 ± 9 | 63 ± 10 |
Sex (male/female) | 48/19 | 20/0 | 26/15 | 141/22 |
Body weight, kg | 62 ± 11* | 72 ± 7 | 59 ± 9 | 66.1 ± 10.9 |
Body mass index, kg/m2 | 22.1 ± 3.0* | 25.8 ± 2.8 | 23.3 ± 3.1 | 24.7 ± 3.2 |
Heart disease etiology: ischemic (%) | NA | NA | 76 | 84 |
Weber class: A/B/C/D† | NA | NA | ||
Using VO2peak (n) | 7/12/20/2 | NA | ||
Using VAT (n) | 1/16/18/6 | 11/40/66/29 | ||
Medications (n) | NA | |||
ACE or ARB | 9 | 16 | 91 | |
Diuretic | 2 | 7 | 51 | |
Beta-blocker | 0 | 17 | 72 | |
Inotropics | 0 | 0 | 4 | |
Ca channel blocker | 17 | 7 | 35 | |
Anti-lipidemic | 3 | 16 | 85 | |
Anti-diabetic | 2 | 4 | 42 |